stella
beta
A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) — Stella
Recruiting
Back to Metabolic Dysfunction-associated Steatohepatitis (MASH) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Beijing Tsinghua ChangGung Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov